These analyses provide evidence that differential expression of risk genes (PICALM, ADAM10, MEF2D, CD46 and IRAK3) with AD contribute to immune activation, angiogenic and apoptosis-related transcriptomic vascular pathologies. The gene discussed is MEF2D; the disease is Alzheimer disease.